Status:
COMPLETED
Methylprednisolone vs Dexamethasone Interaction With Sugammadex in Pediatric Patients
Lead Sponsor:
Konya City Hospital
Conditions:
Neuromuscular Block, Residual
Pain Management
Eligibility:
All Genders
5-12 years
Phase:
NA
Brief Summary
This randomized controlled trial aims to compare the interaction of methylprednisolone and dexamethasone with sugammadex in pediatric patients undergoing adenoidectomy and/or tonsillectomy. The primar...
Detailed Description
Neuromuscular blocking agents (NMBAs) are widely used in pediatric anesthesia to facilitate tracheal intubation and optimize surgical conditions. However, residual neuromuscular block may increase the...
Eligibility Criteria
Inclusion
- Children aged 5-12 years
- American Society of Anesthesiologists (ASA) physical status I-II
Exclusion
- ASA physical status ≥ III
- Emergency surgery
- Known allergy or contraindication to neuromuscular blocking agents, sugammadex, or corticosteroids
- Chronic or recent systemic corticosteroid use (within the last 3 months)
- Neuromuscular disorders (e.g., muscular dystrophy, myasthenia gravis)
- Severe hepatic or renal dysfunction
- Significant respiratory or cardiac disease
- Anticipated difficult airway or history of difficult intubation
- Developmental delay or craniofacial anomalies affecting airway management
- Refusal of consent
Key Trial Info
Start Date :
September 16 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07175623
Start Date
September 16 2025
End Date
December 20 2025
Last Update
December 29 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Konya City Hospital
Konya, Karatay, Turkey (Türkiye), 42050
2
Bezmialem Vakıf Univerisity Dragos Hospital
Istanbul, Turkey (Türkiye)